At Diagnosis
When tissue is insufficient or inaccessible, or when a fast, noninvasive option is needed.
For Providers
Biopsies can be stressful, and for many patients they are painful, risky or impossible because of tumor location or overall health. CellSight™ gives you the key information about a cancer from a blood draw.
CellSight™ isolates and analyzes intact tumor cells. ctDNA assays capture only the DNA fragments shed into the bloodstream.
CellSight™ supports decisions when traditional biopsies fall short.
When tissue is insufficient or inaccessible, or when a fast, noninvasive option is needed.
To identify resistance mutations and adjust therapy.
For patients with high-risk comorbidities or deep tumor sites.
SNVs, indels and copy number variants across a comprehensive solid tumor panel.
Reported to guide immunotherapy decisions.
From specimen receipt to signed-out report.
Designed for clinical use, with the CTC count for the accession.
CellSight™ DNA uses a dedicated collection kit. Specimens collected in Streck or EDTA tubes cannot be processed.
Register your practice for Client Portal access. Existing clients sign in to order.
Each kit contains CellSave CTC Preservation Tubes, a Test Requisition Form and prepaid return shipping.
Draw two 10 mL CellSave tubes, filled to the line. Invert gently 8 to 10 times to mix; do not shake. Label both tubes with patient information and the TRF number.
Fill in all fields: provider information, patient demographics, diagnosis and test requests. Place the TRF in the outer sleeve.
Place the tubes in the biohazard bag with liner, add the frozen ice pack below, and seal at 2 to 8 °C. Call the courier or FedEx for same-day pickup and confirm lab receipt.
Reports are released to the Client Portal in 10 to 14 days from specimen receipt.
From the CellSight™ DNA Test Requisition Form.
| Volume | Two 10 mL tubes of peripheral whole blood, filled to the line |
|---|---|
| Tube | CellSave CTC Preservation Tubes (kit supplied); invert 8 to 10 times, do not shake |
| Not accepted | Streck, EDTA or other cfDNA tubes |
| Transport | Chilled at 2 to 8 °C with the frozen ice pack in the kit |
| Shipping | Same-day courier or FedEx pickup; confirm lab receipt |
| Mobile phlebotomy | Available; request on the Test Requisition Form |
| Provider support | (561) 284-6377, clientservices@cancercelldx.com |
CellSight™ uses a proprietary enrichment and recovery workflow to isolate rare circulating tumor cells from whole blood. The cells are then sequenced for tumor-specific mutations, amplifications and genomic signatures, without tissue.

ctDNA tests sequence cell-free DNA fragments from plasma. CellSight™ DNA isolates intact circulating tumor cells and sequences the DNA inside them. The DNA we analyze has a known tumor-cell origin, and we report how many tumor cells were found.
SNVs, indels and CNVs across 517 genes, TMB, MSI status and the CTC count for the accession.
10 to 14 days from specimen receipt at our laboratory.
No. The assay requires CellSave CTC Preservation Tubes, which are supplied in the kit. Streck and EDTA tubes do not preserve intact cells for this workflow.
Yes. Contact us if the trial requires a specific data format or report delivery.
Connect With Us
For test ordering, validation data or clinical support, contact our team.